Health · Cyprus
AI summary: catch up in 20 seconds
Summarising the coverage…
Generated by AI from the 5 sources below · always verify with the originals
The full picture
AI-synthesised from 5 sources · no editorial bias
Synthesis generating…
AI summary: catch up in 20 seconds
Generated by AI from the 5 sources below · always verify with the originals
The full picture
AI-synthesised from 5 sources · no editorial bias
Remedica Limited has issued a public recall of its medication Remethan 100mg extended-release tablets, advising patients to cease usage immediately and return any remaining product to local pharmacies. This action follows a voluntary recall due to safety concerns associated with specific batches of the drug, which is used primarily as an anti-inflammatory treatment.
Patients currently using Remethan are urged to check the batch numbers and discontinue their use as a precautionary measure. The company has emphasized the importance of this recall to safeguard patient health and has encouraged users to seek alternative treatments if necessary. The exact reasons for the recall have not been detailed in the announcements, but the company is taking this step in an effort to ensure the safety and well-being of its customers.
14 July
Αυτό είναι το γνωστό φάρμακο που αποσύρεται από τη Remedica (εικόνα)
Skip to content
Comments · 0 (subscribers)
Sign in to join the discussion.
No comments yet. Be the first to join the discussion.